Pacific Biosciences of California, Inc. (PACB) Posts Q3 Loss of 41c/Share
Pacific Biosciences of California, Inc. (NASDAQ: PACB) reported Q3 EPS of ($0.41), $0.02 better than the analyst estimate of ($0.43). Revenue for the quarter came in at $2.8 million versus the consensus estimate of $3.12 million.
For earnings history and earnings-related data on Pacific Biosciences of California, Inc. (PACB) click here.
For earnings history and earnings-related data on Pacific Biosciences of California, Inc. (PACB) click here.